• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 22.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Frank Taylor, USA

    Frank Taylor, USA

  • Mike Cels, Canada

    Mike Cels, Canada

  • Jon Newsome, USA

    Jon Newsome, USA

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Lee Millard, England

    Lee Millard, England

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Jean

    Jean
    jean

  • Ali Var, Turkey

    Ali Var, Turkey

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Paul Launer, USA

    Paul Launer, USA

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Ann Nicol, USA

    Ann Nicol, USA

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Phil Rossall, UK

    Phil Rossall, UK

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • David Solomon, UK

    David Solomon, UK

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Daniel Hare, USA

    Daniel Hare, USA

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Anna Barrow, UK

    Anna Barrow, UK

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login